New technology will be in place from January 31 to monitor advertisements on social media relating to the promotion of prescription-only medicines (POMs) such as botulinum toxin.
An Enforcement Notice on January 31 highlighting the rules and concerns around botulinum toxin advertising and other prescription-only medicines on social media has prompted a surge of enquiries to the Advertising Standards Authority (ASA).
The Committees of Advertising Practice (CAP) and Medicines and Healthcare products Regulatory Agency (MHRA) have issued an Enforcement Notice to the beauty and cosmetic services industry urging businesses to review adverts and make immediate changes.
The Advertising Standards Authority (ASA) has upheld its decision for skincare supplement brand Dermacoll to revoke marketing claims in regards to a collagen drink it was promoting on its website.
The Committees of Advertising Practice (CAP) has issued an Enforcement Notice following recent reports of education providers not adhering to its advertising rules for promoting training for injectable procedures.
The Advertising Standards Authority (ASA) has banned an Instagram post by Beauty Boutique Aesthetics after a complaint regarding misleading advertising and the advertisement of a prescription-only medicine.
Epionce has launched Intense Defense Serum.
The Joint Council for Cosmetic Practitioners (JCCP) has raised concerns over vague and misleading advertising language used by aesthetic training companies to the Advertising Standards Authority (ASA).
The Advertising Standards Authority (ASA) has ruled a London clinic’s labiaplasty marketing as “irresponsible” following several complaints of an advertisement in The Metro on February 9.
Skincare company Murad has added two new products to its portfolio; the Multi-Vitamin Infusion Oil and the Outsmart Blemish Clarifying Treatment.